News tagged with generic competition
UK alleges GSK paid off competitors to delay drugs
Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.
Medications
Apr 19, 2013 |
not rated yet |
1
US Justice Department appeals morning-after case
(AP)—The Obama administration appealed a federal judge's order to lift all age limits on who can buy morning-after birth control pills without a prescription. In appealing the ruling on Wednesday, the administration ...
Medications
May 02, 2013 |
4 / 5 (1) |
0
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
Pfizer Q1 profit up, but drugmaker cuts outlook
Pfizer Inc.'s first-quarter net income rose 53 percent despite falling sales, mainly because the world's second-largest drugmaker took big charges a year ago. Pfizer's results fell short of Wall Street's ...
Other
Apr 30, 2013 |
not rated yet |
0
FDA outlines path for lower-priced biotech drugs
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.
Medications
Feb 09, 2012 |
not rated yet |
1
US probes Sanofi over blockbuster drug Plavix (Update 2)
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications
Mar 11, 2013 |
not rated yet |
0
'Generic' medical devices could cut into name-brand profits
Generic competition - a billion-dollar problem for brand-name drug companies since the 1980s - is making inroads in the orthopedic medical devices industry. Last week Cardinal Health Inc., one of the three biggest device ...
Medications
Jul 27, 2012 |
not rated yet |
0
With new generic rivals, Lipitor's sales halved
Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.
Medications
Dec 20, 2011 |
not rated yet |
3
Drug prices to plummet in wave of expiring patents
The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the top ...
Medications
Jul 25, 2011 |
5 / 5 (3) |
4
Drugmaker Ranbaxy halts generic Lipitor production
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were ...
Medications
Nov 30, 2012 |
not rated yet |
0
Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other
Jan 29, 2013 |
not rated yet |
0
AstraZeneca reorg to cut 1,600 jobs in US, UK
(AP)—Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization.
Medications
Mar 18, 2013 |
not rated yet |
0
Eli Lilly 2013 profit forecast tops expectations
(AP)—Eli Lilly and Co. said Friday its 2013 earnings will grow more than Wall Street expects, even though the drugmaker will lose U.S. patent protection for two more key products this year.
Other
Jan 04, 2013 |
not rated yet |
0
AstaZeneca in patent warning as net profit falls
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
Other
Jan 31, 2013 |
not rated yet |
0
